PPT-FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY

Case study 9 Provided by Dr Qamar Ghafoor Clinical Oncology Consultant University Hospital Birmingham TAGRISSO osimertinib Prescribing Information for Great Britain may be found here. Renato G. Martins, MD, MPH. Medical Director, Thoracic/Head and Neck; General Oncology and Hematology. Seattle Cancer Care Alliance. July 28, 2015. 11:30 am – 12:30 pm, EST. ICLIO e-Course 02. Objectives. MD. The Evolving Treatment Landscape in NSCLC: Congress Updates. Outline of Talk. Provide a brief overview of current advances in the treatment of NSCLC. EGFR-targeted agents . ALK-EML4 targeted agents . Build . a completely hypothetical business (meaning it is just an idea at this point) with a goal of getting investor capital, a bank loan and a line of credit. It can be a made up “widget . company”, . The Coming Paradigm Shift. Faculty. Suresh S. Ramalingam, MD. Professor of Hematology/Oncology . Director, Lung . Cancer Program . Winship Cancer Institute. Emory University. Atlanta, . Georgia. Program Goals. April 2010 CE. Condell Medical Center EMS System. Prepared by: Lt. William Hoover, Medical Officer. Wauconda Fire District. Reviewed/revised by: Sharon Hopkins, RN, BSN, EMT-P. Revised 4.12.10. 2. Objectives. of Long Duration. Ruben A. Mesa, MD, FACP. Chair, Division of Hematology & Medical Oncology. Deputy Director, Mayo Clinic Cancer Center. Professor of Medicine. Co-Presenters. Jeffrey C. Bryan, . PharmD. actual. . video-recorded proceedings from the . live . CME event and may include the use of trade names and other raw, unedited content. . Disclosures for . Dr. Langer. Advisory Committee. Abbott Laboratories, AstraZeneca Pharmaceuticals LP, . proceedings from the live CME event and may include . the use of trade names and other raw, unedited content. . Moderator. Neil Love, MD. Faculty . Oncology Grand Rounds. . Emerging Strategies in Non-Small Cell Lung Cancer. actual. . video-recorded proceedings from the . live . CME event and may include the use of trade names and other raw, unedited content. . Consensus OR Controversy? . Clinical Investigators Provide Perspectives on the Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Without Targetable Tumor Mutations . The People's Hospital of Zhengzhou-Yihe HospitalSamsung displays and solutions enhance patient communications at Yihe Hospital with near real-time information delivery OverviewCustomer Need Yihe Hospi Home. Sloan Manning, MD. Disclosures. Dr. Manning has disclosed the following relationships:. He has received grant/research support from Pearson Clinical Assessments; he has consulted for . Sunovion. Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum. Friday, October 11, 2019. 6:15 PM – 7:45 PM . Chicago, Illinois. Faculty. . Moderator. Joel W Neal, MD, PhD. Nasser H Hanna, MD. Università . di Napoli “Federico II”. Innovation. in 2nd . line. treatment . of. NSCLC. Multi-target. . agents. and. . angiogenesis. Blocking. the RAS/MEK. . signaling. Antibodies. . against. Optimal Management of Metastatic . Non-Small Cell Lung Cancer. Faculty. . Moderator. Neil Love, MD. Hossein . Borghaei. , DO, MS . Julie R . Brahmer. , MD. Edward B . Garon. , MD, MS. Ramaswamy Govindan, MD.